Prospective Changes in Health-Related Quality of Life and Emotional Outcomes in Kidney Transplantation over 6 Years
Table 2
Patient reported outcomes at baseline and 6-year followup: total transplant sample; Cadaver transplant and living related transplant recipients.
CAD TX
LRD TX
Total Sample
value
T1
T2
T1
T2
T1
T2
Mean (SD)
Mean (SD)
Mean (SD)
Mean (SD)
Mean (SD)
Mean (SD)
SF-36
MCS
45.84 (6.72)
50.82 (11.05)
43.50 (4.69)
49.73 (8.35)
45.30 (6.36)
50.57 (10.45)
.000
PCS
44.93 (12.30)
41.84 (12.29)
51.40 (7.15)
39.80 (14.70)
46.41 (11.61)
41.37 (12.80)
.001
PF
38.89 (16.91)
38.55 (16.47)
50.73 (6.21)
41.46 (13.79)
41.28 (16.06)
39.14 (15.94)
ns
RPh
45.88 (9.53)
45.06 (10.37)
51.14 (4.68)
46.73 (8.83)
46.94 (9.00)
45.39 (10.05)
ns
Rem
50.50 (6.88)
48.36 (10.01)
52.60 (4.17)
50.56 (7.10)
50.93 (6.45)
48.81 (9.49)
.037
SF
40.14 (10.38)
39.62 (14.65)
45.90 (7.27)
45.62 (11.24)
41.34 (10.06)
40.87 (14.17)
ns
MH
41.65 (9.19)
49.47 (12.59)
42.44 (5.67)
51.52 (9.36)
41.84 (8.54)
49.91 (11.96)
.000
VT
44.65 (7.18)
48.97 (10.92)
43.83 (6.09)
45.86 (10.24)
44.47 (6.94)
48.30 (10.80)
.000
BP
48.11 (11.40)
45.14 (13.15)
52.89 (8.29)
44.70 (13.91)
49.11 (10.95)
45.05 (13.24)
.002
GH
43.01 (11.55)
41.29 (13.14)
43.51 (10.04)
39.54 (9.72)
43.11 (11.21)
40.94 (12.51)
ns
TxEQ
Worry
3.03 (.88)
3.25 (.71)
3.07 (.87)
3.30 (.77)
3.04 (.87)
3.26 (.72)
.036
Guilt
2.13 (.60)
2.25 (.78)
2.61 (.74)
2.55 (.73)
2.23 (.66)
2.32 (.77)
ns
Disclos
3.95 (.82)
3.96 (.99)
3.59 (1.15)
4.05 (1.04)
3.88 (.90)
3.98 (.99)
ns
Adherence
4.30 (.71)
4.28 (.76)
4.19 (1.11)
4.00 (1.00)
4.27 (.81)
4.22 (.82)
ns
Responsibility
3.72 (.71)
3.97 (.85)
3.71 (.74)
3.96 (.76)
3.72 (.71)
3.97 (.83)
.008
CAD: cadaver; TX: transplant; LRD: living related donor; T1: baseline; T2: 6-year followup; GH: general health; PF: physical functioning; BP: bodily pain; VT: vitality; RPh: role limitations due to physical problems; REm: role limitations due to emotional problems; SF: social functioning; MH: mental health; MCS: mental component score; PCS: physical component scores; TXEQ: Transplant effects questionnaire; Disclos: disclosure. †Normative based scoring: In all SF-36 sub-scales the general population mean is 50 and 10 is a standard deviation. †† value reported based on repeated measure ANOVAs conducted on total sample.
